NCT05397548View on ClinicalTrials.gov

Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer

UnknownOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2023

Conditions
Gastric Cancer
Interventions
DIAGNOSTIC_TEST

Measurement of levels of circulating exosomal lncRNA-GC1

Each participant was enrolled to assess the levels of circulating exosomal lncRNA-GC1

Trial Locations (1)

100853

RECRUITING

Xinxin Wang, Beijing

Sponsors

Lead Sponsor

Lin Chen
All Listed Sponsors
collaborator

Xijing Hospital

OTHER

lead

Lin Chen

OTHER